Edward Sitar

Ed Sitar, CPA, Chair of our Audit Committee has extensive financial leadership in public Companies and has served as CFO in a variety of public companies including 9 Meters Biopharma (Nasdaq:NMTR), Cancer Genetics (Nasdaq:CGIX), Active Health Management (subsidiary of Aetna - Nasdaq AET), Vital Signs (Nasdaq:VITL) and MIM corporation (now BioScrip - Nasdaq:BIOS).